REVIR Trademark

Trademark Overview


On Thursday, December 30, 2021, a trademark application was filed for REVIR with the United States Patent and Trademark Office. The USPTO has given the REVIR trademark a serial number of 97196739. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, April 25, 2023. This trademark is owned by Revir Therapeutics, Inc.. The REVIR trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical services; Medical consulting services in the field of disease infection control; Providing medical care services and consultation related thereto; Pharmaceutical and medical consultancy; Providing healthcare information and advisory services in the healthcare field; Medical consultation services featuring preparation of reports relating to medical and pharmaceutical services; Medical services, namely, providing therapies for treating proliferating diseases, cancers, infectious diseases, autoimmune diseases, metabolic diseases and neurodegenerative disease; Medical services, namely, providing therapeutic and prophylactic treatment of proliferating diseases, cancers, infectious diseases, autoimmune diseases, metabolic diseases, and neurodegenerative disease; Medical and pharmaceutical consultation; Medical diagnostic testing, monitoring and reporting services; Genetic testing for medical purposes
revir

General Information


Serial Number97196739
Word MarkREVIR
Filing DateThursday, December 30, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, April 25, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical services; Medical consulting services in the field of disease infection control; Providing medical care services and consultation related thereto; Pharmaceutical and medical consultancy; Providing healthcare information and advisory services in the healthcare field; Medical consultation services featuring preparation of reports relating to medical and pharmaceutical services; Medical services, namely, providing therapies for treating proliferating diseases, cancers, infectious diseases, autoimmune diseases, metabolic diseases and neurodegenerative disease; Medical services, namely, providing therapeutic and prophylactic treatment of proliferating diseases, cancers, infectious diseases, autoimmune diseases, metabolic diseases, and neurodegenerative disease; Medical and pharmaceutical consultation; Medical diagnostic testing, monitoring and reporting services; Genetic testing for medical purposes

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 5, 2022
Primary Code044
First Use Anywhere DateMonday, May 10, 2021
First Use In Commerce DateMonday, May 10, 2021

Trademark Owner History


Party NameRevir Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFoster City, CA 94404

Trademark Events


Event DateEvent Description
Tuesday, April 25, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, April 25, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, April 25, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, October 11, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 11, 2022NON-FINAL ACTION E-MAILED
Tuesday, October 11, 2022NON-FINAL ACTION WRITTEN
Tuesday, October 4, 2022ASSIGNED TO EXAMINER
Thursday, September 1, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 1, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, September 1, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 1, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 5, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 3, 2022NEW APPLICATION ENTERED